about
Modifications of antiepileptic drugs for improved tolerability and efficacyComputational study of synthetic agonist ligands of ionotropic glutamate receptorsGenetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS)Streptococcus thermophilus APC151 Strain Is Suitable for the Manufacture of Naturally GABA-Enriched Bioactive YogurtFunctional expression, purification and high sequence coverage mass spectrometric characterization of human excitatory amino acid transporter EAAT2Experimental measles encephalitis in Lewis rats: dissemination of infected neuronal cell subtypes.Lactic Acid Bacteria and Bifidobacteria with Potential to Design Natural Biofunctional Health-Promoting Dairy FoodsRice Bran Metabolome Contains Amino Acids, Vitamins & Cofactors, and Phytochemicals with Medicinal and Nutritional Properties.On the chemical mechanism of succinic semialdehyde dehydrogenase (GabD1) from Mycobacterium tuberculosisGeneration and screening of oxime libraries addressing the neuronal GABA transporter GAT1.A clinical study to assess CYP1A2 and CYP3A4 induction by AZD7325, a selective GABA(A) receptor modulator - an in vitro and in vivo comparison.Effects of metabotropic glutamate receptor ligands on male sexual behavior in rats.Modulating inhibitory ligand-gated ion channels.Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challengesGABAA receptors, anesthetics and anticonvulsants in brain development.Pituitary Adenylate cyclase-activating polypeptide orchestrates neuronal regulation of the astrocytic glutamate-releasing mechanism system xc (.).Excitatory amino acid transporters as potential drug targets.NAD+ Attenuates Bilirubin-Induced Hyperexcitation in the Ventral Cochlear Nucleus by Inhibiting Excitatory Neurotransmission and Neuronal Excitability.Probing the orthosteric binding site of GABAA receptors with heterocyclic GABA carboxylic acid bioisosteres.Allosteric therapies for lung cancer.Central inhibition of initiation of swallowing by systemic administration of diazepam and baclofen in anaesthetized rats.Pharmacological Potential and Synthetic Approaches of Imidazo[4,5-b]pyridine and Imidazo[4,5-c]pyridine Derivatives.Benzodiazines: recent synthetic advances.Synthesis and preliminary pharmacological evaluation of novel derivatives of L-beta-threo-benzylaspartate as inhibitors of the neuronal glutamate transporter EAAT3The role of CA3 GABAA receptors on anxiolytic-like behaviors and avoidance memory deficit induced by NMDA receptor antagonists.Efficacy of Cerebrolysin in the reduction of spasticity during stroke rehabilitation.Characterization of a recombinant (-)γ-lactamase from Microbacterium hydrocarbonoxydans.Endogenous concentrations, pharmacokinetics, and selected pharmacodynamic effects of a single dose of exogenous GABA in horses.Screening of Natural Bioactive Metabolites and Investigation of Antioxidant, Antimicrobial, Antihyperglycemic, Neuropharmacological, and Cytotoxicity Potentials of Litsea polyantha Juss. Ethanolic Root Extract.BPC 157 antagonized the general anaesthetic potency of thiopental and reduced prolongation of anaesthesia induced by L-NAME/thiopental combination.Neuroprotective potential of astroglia.Acute sleep deprivation: the effects of the AMPAKINE compound CX717 on human cognitive performance, alertness and recovery sleep.Discovery of α-Substituted Imidazole-4-acetic Acid Analogues as a Novel Class of ρ1 γ-Aminobutyric Acid Type A Receptor Antagonists with Effect on Retinal Vascular Tone.Prenatal bystander stress alters brain, behavior, and the epigenome of developing rat offspring.Interactions Between Epilepsy and Plasticity.Development of Highly Potent GAT1 Inhibitors: Synthesis of Nipecotic Acid Derivatives with N-Arylalkynyl Substituents.Methyl-inositol, γ-aminobutyric acid and other health benefit compounds in the aril of litchi.
P2860
Q24651951-067C375A-CBBF-4619-9BC7-6CCDFFE59A01Q27334812-D454C180-2382-446C-8301-12488F120945Q28652508-52239A36-BF2C-46F9-8E15-4244613747A9Q28820816-988D5FB1-A325-4FC1-ABCF-F0FA162A0790Q30981324-67EA3636-AA93-4B0E-A7A4-E844C89D233BQ31136191-61F993B7-4504-41FF-93F6-DA2B56E0AB09Q33700724-E8417F35-EF97-4D8E-8CFB-E442A1B7C7F5Q33752722-3F26D5E6-C087-4B5F-AEAF-863E58DFBF2DQ34982365-FE5AFC6A-FBB5-4B26-B57E-794266159A72Q35393157-2BF27C9A-215B-464B-92F7-2838853D38BFQ36087970-D58CE298-4633-4167-9F7B-470A128FD425Q36472772-2DA91F68-FD95-4BA9-9385-46B1DF0A70E7Q36516836-1F14376C-50F5-48A4-9F66-FF2B8C190C4AQ36524716-488A14DD-CAEC-4690-B3B9-65ED963D38F3Q36917900-AC26DF9A-0641-44B7-A896-D16C1736E76BQ36930072-A8BF9380-51F3-4FD6-AB09-09CF82097CF6Q37489935-79BDF40E-06FA-4D9B-B96C-30E1D68F5B94Q37622026-B6C1463C-9756-4872-AA31-561FE001986AQ38173266-7102FC86-73AA-4F0E-9C2B-D50C4AF99C93Q38465098-9D935D9E-3B1A-4162-9A8B-DECFB34DBBA1Q38932318-27248537-8FA4-4F65-92A2-5E923E3F3E2BQ39168834-1E5A0EB0-4809-44AA-9344-E20E6258F059Q39269222-A0D14B6B-7E6E-407E-A84C-3652C046BC75Q39958018-33B659CD-866C-4889-810A-04671001CB23Q40119374-CECD0AF9-830D-423C-963C-279DFC5FCD46Q42650695-CCC19531-0610-4992-AA73-38EB3DB4D21FQ43827518-1A130898-ED8A-49AF-95CD-A3E517D234CAQ46510543-A2923D73-FD32-42C3-9899-96290210D9A8Q47106061-C5C6E217-8C4C-49EE-B6BF-D5E5D9A54F4CQ47628017-AC1609EE-50F0-4AB8-AD76-185B12DACE5FQ47916378-50468F60-6D7E-4943-9CDF-2E10806D3F8AQ48281915-64652A03-A929-429A-B380-34063CAFD051Q48472564-125DC9D3-7B61-4956-B187-D705F0433404Q48915949-56F5CC2C-03F3-4826-8713-87B731650190Q50133892-A3D37338-F4AA-4F3D-83D9-35129A852105Q51167808-7B521B91-B71A-4BF1-ACC3-8CE14B6CFEA5Q51287325-63FBF0C4-5650-4042-B5D5-933B1DEFB179
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Glutamate- and GABA-based CNS therapeutics
@ast
Glutamate- and GABA-based CNS therapeutics
@en
Glutamate- and GABA-based CNS therapeutics
@en-gb
Glutamate- and GABA-based CNS therapeutics
@nl
type
label
Glutamate- and GABA-based CNS therapeutics
@ast
Glutamate- and GABA-based CNS therapeutics
@en
Glutamate- and GABA-based CNS therapeutics
@en-gb
Glutamate- and GABA-based CNS therapeutics
@nl
prefLabel
Glutamate- and GABA-based CNS therapeutics
@ast
Glutamate- and GABA-based CNS therapeutics
@en
Glutamate- and GABA-based CNS therapeutics
@en-gb
Glutamate- and GABA-based CNS therapeutics
@nl
P1476
Glutamate- and GABA-based CNS therapeutics
@en
P356
10.1016/J.COPH.2005.11.005
P407
P577
2006-02-01T00:00:00Z